daGOAT-Guided Prevention of Severe aGVHD After Allo-HSCT
Clinical trial NCT07588945 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07588945
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-01
- Primary completion
- 2027-12-31
- Enrollment
- 438
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.